Cesarman-Maus et al. [59] raised the hypothesis that anti-ANXA2 autoantibodies may promote hypercoagulation and fibrin deposition by inhibiting t-PA-dependent plasmin formation. The gene discussed is PLAT; the disease is thrombophilia.